Search
The Opportunity At The Kids Research Institute Australia, we are bringing together community, researchers, practitioners, policy makers and funders,
The Opportunity An opportunity for an experienced Research Officer to cover a period of Maternity Leave relief 2-3 days per week from February 2019
Research
Interferon-α2b Treatment for COVID-19We describe here the effects of treatment with interferon-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China
Research
Mental Health Issues and Complex Experiences of Abuse Among Trans and Gender Diverse Young People: Findings from Trans PathwaysThose working in trans and gender diverse health care need to be aware of the high prevalence of violence and abuse among trans and gender diverse young people
Research
Reflections and perceptions of chronic tinnitus during childhoodReflections and perceptions of chronic tinnitus during childhood
Research
The Demographic and Neurocognitive Profile of Clients Diagnosed With Fetal Alcohol Spectrum Disorder in PATCHES Paediatrics ClinicsThe aim of this study was to describe the demographic and neurocognitive profile of the first 199 individuals diagnosed with FASD in PATCHES Paediatrics clinics
Research
The effect of parental logistic support on physical activity in children with, or at risk of, movement difficultiesChildren's perceptions of parents' logistic support for physical activity indirectly and positively predicts children's physical activity levels
Research
Expanding the phenotype of the CDKL5 deficiency disorder: Are seizures mandatory?These cases, both without seizures but with apparent behavioral symptomatology, together question whether seizures are mandatory in this disorder
Research
A comparison of major trauma patient transport destination in metropolitan Perth, Western AustraliaThis study examines the characteristics and outcomes of major trauma patients between transport destinations
Research
Screening and Management Practices for Polyoma (BK) Viremia and Nephropathy in Kidney Transplant Recipients From the Lands Down Under: Addressing the Unknowns and Rationale for a Multicenter Clinical TrialBK polyomavirus infection in transplanted kidneys that leads to BK virus–associated nephropathy (BKVAN) is an important cause of allograft loss and has limited treatment options. Recent data suggest that BK viremia affects approximately 10% of people within the first 12 months following kidney transplantation. Among recipients with BKVAN, the overall risk of allograft loss is substantially increased, estimated to be 50% within 5 years of diagnosis.